Why is approval of an ethics review board suggested prior to beginning topical immunotherapy for alopecia areata?

Updated: Jun 07, 2018
  • Author: Chantal Bolduc, MD, FRCPC; Chief Editor: Dirk M Elston, MD  more...
  • Print
Answer

Because topical immunotherapy involves the production of contact sensitivity in a previously naive patient, it is best to seek approval for the treatment by the ethics review board and to have the patient sign an informed consent.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!